Home > Cardiology > ESC 2021 > 2021 ESC Clinical Practice Guidelines > 2021 ESC Guidelines on Cardiovascular Disease Prevention

2021 ESC Guidelines on Cardiovascular Disease Prevention

Presented By
Prof. Frank Visseren, Guidelines Task Force Chair
ESC 2021
Estimation of cardiovascular disease risk remains a cornerstone in the new 2021 ESC Guidelines. A novel stepwise treatment intensification approach with age-specific thresholds is recommended to control risk factors. The new 2021 Guidelines on Cardiovascular Disease (CVD) Prevention were presented by Prof. Frank Visseren (Guidelines Task Force Chair; University Medical Center Utrecht, the Netherlands) at the ESC Congress 2021 and published simultaneously in the European Heart Journal [1,2]. “We wanted to make more personalised CVD prevention guidelines instead of a one-size-fits-all and focus more on the elderly,” said Prof. Visseren in his overview of the new guidelines. The most important changes in the 2021 CVD Prevention Guidelines include: A stepwise approach to individualised CVD prevention. Applying the SCORE2 and SCORE2-OP for 4 geographic regions. Age-specific risk thr...

Please login to read the full text of the article.

If you have no account yet, please register now.

Posted on